Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Juliang, He"'
Autor:
Yun Liu, Mingwei He, Haijun Tang, Tianyu Xie, Yunhua Lin, Shangyu Liu, Jiming Liang, Feicui Li, Kai Luo, Mingxiu Yang, Hongcai Teng, Xiaoting Luo, Juliang He, Shijie Liao, Qian Huang, Wenyu Feng, Xinli Zhan, Qingjun Wei
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-19 (2024)
Abstract Background Osteosarcoma (OS) is the most common primary malignant bone tumor and is highly prone to metastasis. OS can metastasize to the lymph node (LN) through the lymphatics, and the metastasis of tumor cells reestablishes the immune land
Externí odkaz:
https://doaj.org/article/5be719550a4d429392df62c4f336611d
Autor:
Xianying Huang, Yongjin Liu, Weifeng Liang, Kai Luo, Yiwu Qin, Feicui Li, Tianyu Xie, Haibiao Qin, Juliang He, Qingjun Wei
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background The purpose of this study was to investigate the significance of preoperative C-reactive protein-to-albumin ratio (CAR), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in predicting overall survival (O
Externí odkaz:
https://doaj.org/article/d8541d2d69284e0cb880c80203409a9f
Autor:
Chengsen Lin, Jifeng Miao, Juliang He, Wenyu Feng, Xianxiang Chen, Xiaohong Jiang, Jianhong Liu, Boxiang Li, Qian Huang, Shijie Liao, Yun Liu
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Aberrantly expressed lncRNAs have been reported to be closely related to the oncogenesis and development of osteosarcoma. However, the role of a dysregulated lncRNA-miRNA-mRNA network in osteosarcoma in the same individual needs to be furthe
Externí odkaz:
https://doaj.org/article/f62379aa845f40a6b327a9c49dee5350
Autor:
Haijun Tang, Dehuai Liu, Jili Lu, Juliang He, Shuyu Ji, Shijie Liao, Qingjun Wei, Shenglin Lu, Yun Liu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background At present, no predictive factor has been validated for the early efficacy of neoadjuvant chemotherapy (NACT) in osteosarcoma. The purpose of this study was to investigate the significance of the neutrophil-to-lymphocyte ratio (NL
Externí odkaz:
https://doaj.org/article/8f2b92f888e341808162f3637e39635e
Autor:
Yun Liu, Wenyu Feng, Yan Dai, Mengying Bao, Zhenchao Yuan, Mingwei He, Zhaojie Qin, Shijie Liao, Juliang He, Qian Huang, Zhenyuan Yu, Yanyu Zeng, Binqian Guo, Rong Huang, Rirong Yang, Yonghua Jiang, Jinling Liao, Zengming Xiao, Xinli Zhan, Chengsen Lin, Jiake Xu, Yu Ye, Jie Ma, Qingjun Wei, Zengnan Mo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/5ed6bb317db346d0a6725bd4cdc6fb6d
Autor:
Wenyu Feng, Mingwei He, Xiaohong Jiang, Huijiang Liu, Tianyu Xie, Zhaojie Qin, Qian Huang, Shijie Liao, Chengsen Lin, Juliang He, Jiake Xu, Jie Ma, Yun Liu, Qingjun Wei
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Giant cell tumor of bone (GCTB) is benign tumor that can cause significant osteolysis and bone destruction at the epiphysis of long bones. Osteoclasts are thought to be highly associated with osteolysis in GCTB. However, the migration of osteoclasts
Externí odkaz:
https://doaj.org/article/d6085f0260c54ca79eeb1ae1bde68d8f
Autor:
Yun Liu, Wenyu Feng, Yan Dai, Mengying Bao, Zhenchao Yuan, Mingwei He, Zhaojie Qin, Shijie Liao, Juliang He, Qian Huang, Zhenyuan Yu, Yanyu Zeng, Binqian Guo, Rong Huang, Rirong Yang, Yonghua Jiang, Jinling Liao, Zengming Xiao, Xinli Zhan, Chengsen Lin, Jiake Xu, Yu Ye, Jie Ma, Qingjun Wei, Zengnan Mo
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Osteosarcoma (OS), which occurs most commonly in adolescents, is associated with a high degree of malignancy and poor prognosis. In order to develop an accurate treatment for OS, a deeper understanding of its complex tumor microenvironment (TME) is r
Externí odkaz:
https://doaj.org/article/8b135de44da548f89448dba121e21f40
Autor:
Tianyu Xie, Wenyu Feng, Mingwei He, Xinli Zhan, Shijie Liao, Juliang He, Zhaojie Qin, Feicui Li, Jiake Xu, Yun Liu, Qingjun Wei
Publikováno v:
Exp Biol Med (Maywood)
Osteosarcoma (OS) is a common primary malignant tumor of the bone in children and adolescents. The five-year survival rate is estimated to be ~70% based on the currently available treatment modalities. It is well known that tumor-infiltrating immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d87ed8b0d48335a4cf83ffebe096118
https://doi.org/10.1177/15353702221142607
https://doi.org/10.1177/15353702221142607
Publikováno v:
Experimental and Therapeutic Medicine. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a8cdb69f8baa0c6bbb85338870753ae
https://doi.org/10.3892/etm.2023.11794
https://doi.org/10.3892/etm.2023.11794
Publikováno v:
OncoTargets and therapy
Juliang He,* Jian Guan,* Shian Liao, Zhenjie Wu, Bin Liu, Hao Mo, Zhenchao Yuan Department of Bone and Soft Tissue Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530021, People’s Republic of China*These authors contributed eq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caedc3ed01c5963a227265584fcbb552
https://doi.org/10.2147/ott.s280912
https://doi.org/10.2147/ott.s280912